Intravenous Infusions Plc (GHSE:IIL)
Ghana
· Delayed Price · Currency is GHS 0.0400
0.00 (0.00%)
At close: Aug 6, 2025
Intravenous Infusions Cash Flow Statement
Financials in millions GHS. Fiscal year is January - December.
Millions GHS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -0.64 | 2.54 | -3.51 | 1.15 | 1.45 | Upgrade
|
| Depreciation & Amortization | 0.65 | 0.79 | 0.56 | 0.54 | 0.7 | Upgrade
|
| Other Amortization | 0.01 | 0.01 | 0 | 0.01 | 0.01 | Upgrade
|
| Other Operating Activities | -0.31 | 0.49 | -0.29 | -0.17 | -0.56 | Upgrade
|
| Change in Accounts Receivable | 4.37 | 0.02 | 0.77 | -1 | -0.54 | Upgrade
|
| Change in Inventory | 0.17 | 0.37 | 1.03 | -1.59 | -1.38 | Upgrade
|
| Change in Accounts Payable | 3.9 | 0 | 4.3 | 4.37 | 0.52 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | -0.75 | Upgrade
|
| Operating Cash Flow | 8.16 | 4.23 | 2.87 | 3.3 | -0.54 | Upgrade
|
| Operating Cash Flow Growth | 92.93% | 47.23% | -12.91% | - | - | Upgrade
|
| Capital Expenditures | -1.9 | -1.84 | -2.42 | -7.16 | -3.92 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | - | 0.06 | - | - | Upgrade
|
| Cash Acquisitions | - | -0.01 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0 | -0.02 | -0.01 | - | -0.01 | Upgrade
|
| Investing Cash Flow | -1.89 | -1.87 | -2.37 | -7.16 | -3.92 | Upgrade
|
| Short-Term Debt Issued | - | - | 2 | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 5.75 | 5.95 | Upgrade
|
| Total Debt Issued | - | - | 2 | 5.75 | 5.95 | Upgrade
|
| Short-Term Debt Repaid | -0.71 | -1.09 | -0.23 | - | - | Upgrade
|
| Long-Term Debt Repaid | -3.95 | -2.62 | -1.91 | -1.33 | - | Upgrade
|
| Total Debt Repaid | -4.66 | -3.71 | -2.14 | -1.33 | - | Upgrade
|
| Net Debt Issued (Repaid) | -4.66 | -3.71 | -0.14 | 4.42 | 5.95 | Upgrade
|
| Common Dividends Paid | -0.77 | - | -0.09 | -0.71 | -1.21 | Upgrade
|
| Other Financing Activities | 0.36 | 0.69 | -0.13 | - | - | Upgrade
|
| Financing Cash Flow | -5.07 | -3.02 | -0.36 | 3.71 | 4.75 | Upgrade
|
| Net Cash Flow | 1.19 | -0.66 | 0.15 | -0.15 | 0.28 | Upgrade
|
| Free Cash Flow | 6.26 | 2.39 | 0.45 | -3.86 | -4.46 | Upgrade
|
| Free Cash Flow Growth | 162.29% | 427.29% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 25.09% | 7.59% | 2.22% | -17.03% | -21.58% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.01 | 0.00 | -0.01 | -0.02 | Upgrade
|
| Cash Income Tax Paid | 0.46 | 0.46 | 0.26 | 0.46 | 0.47 | Upgrade
|
| Levered Free Cash Flow | 7.17 | 3.3 | 1.77 | -4.24 | -4.7 | Upgrade
|
| Unlevered Free Cash Flow | 7.26 | 3.75 | 2.02 | -4.14 | -4.5 | Upgrade
|
| Change in Working Capital | 8.45 | 0.39 | 6.1 | 1.78 | -2.15 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.